Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma
-
- Sekiguchi Yasunobu
- Department of Hematology, Saitama Cancer Center, Saitama, Japan,
-
- Tsutsumi Hiroki
- Department of Hematology, Saitama Cancer Center, Saitama, Japan,
-
- Gomyo Ayumi
- Department of Hematology, Saitama Cancer Center, Saitama, Japan,
-
- Kudo Masahisa
- Department of Hematology, Saitama Cancer Center, Saitama, Japan,
-
- Iizaki Yoshie
- Department of Hematology, Saitama Cancer Center, Saitama, Japan,
-
- Maseki Nobuo
- Department of Hematology, Saitama Cancer Center, Saitama, Japan,
-
- Kawamura Machiko
- Department of Hematology, Saitama Cancer Center, Saitama, Japan, Department of Clinical Laboratory Medicine, Saitama Cancer Center, Saitama, Japan,
-
- Kobayashi Kazuhiko
- Department of Inspection Engineering, Saitama Cancer Center, Saitama, Japan,
-
- Nishimura Yu
- Department of Pathology, Saitama Cancer Center, Saitama, Japan,
-
- Kanda Hiroaki
- Department of Pathology, Saitama Cancer Center, Saitama, Japan,
-
- Nitta Hideaki
- Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan
-
- Noguchi Masaaki
- Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan
-
- Kobayashi Hirofumi
- Department of Hematology, Saitama Cancer Center, Saitama, Japan,
この論文をさがす
収録刊行物
-
- Ｊｏｕｒｎａｌ ｏｆ Ｃｌｉｎｉｃａｌ ａｎｄ Ｅｘｐｅｒｉｍｅｎｔａｌ Ｈｅｍａｔｏｐａｔｈｏｌｏｇｙ
-
Ｊｏｕｒｎａｌ ｏｆ Ｃｌｉｎｉｃａｌ ａｎｄ Ｅｘｐｅｒｉｍｅｎｔａｌ Ｈｅｍａｔｏｐａｔｈｏｌｏｇｙ 63 (4), 262-265, 2023-12-26
一般社団法人 日本リンパ腫学会
